Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Frazier Life Sciences Management, L.P.
Form 13F · Q2 2026

Frazier Life Sciences Management, L.P.

CIK 1892134Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$4.6B
Reported book value
41
Positions
12
Quarters on record
Top 50
Positions

Frazier Life Sciences Management, L.P. — holdings

Top 41 positions of 41, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1MIRM Mirum Pharmaceuticals Inc7.7M+0.0%$899M19.6%
2NAMS Newamsterdam Pharma Company18.1M+6.8%$613M13.3%
3ERAS Erasca Inc25.0M+1.2%$458M10.0%
4MBX Mbx Biosciences Inc6.7M+0.0%$367M8.0%
5ARQT Arcutis Biotherapeutics Inc9.9M+0.0%$259M5.6%
6TRVI Trevi Therapeutics Inc9.9M−0.0%$185M4.0%
7KRYS Krystal Biotech Inc481,307+0.0%$179M3.9%
8MAZE Maze Therapeutics Inc5.0M+10.2%$150M3.3%
9PHAT Phathom Pharmaceuticals Inc12.5M+0.0%$135M2.9%
10PVLA Palvella Therapeutics Inc Ne882,400+0.0%$135M2.9%
11BBIO Bridgebio Pharma Inc1.5M−55.1%$115M2.5%
12IRON Disc Medicine Inc1.4M+0.0%$99M2.2%
13CYTK Cytokinetics Inc1.2M+0.0%$99M2.2%
14DYN Dyne Therapeutics Inc3.2M+0.0%$70M1.5%
15ASND Ascendis Pharma A/S225,155+68.9%$60M1.3%
16SVRA Savara Inc9.7M+0.0%$60M1.3%
17PBLS Parabilis Medicines Inc1.9M—$53M1.1%
18AURA Aura Biosciences Inc7.1M+39.2%$50M1.1%
19QUIT Achieve Life Science Inc7.6M—$50M1.1%
20VOR Vor Biopharma Inc2.5M+0.0%$47M1.0%
21ALLO Allogene Therapeutics Inc22.4M+491.2%$47M1.0%
22TARS Tarsus Pharmaceuticals Inc728,644+0.0%$46M1.0%
23BCRX Biocryst Pharmaceuticals Inc4.0M+0.0%$40M0.9%
24ALKS Alkermes Plc700,647+0.0%$37M0.8%
25ACAD Acadia Pharmaceuticals Inc1.4M+0.0%$36M0.8%
26ZLAB Zai Lab Ltd1.9M+0.0%$36M0.8%
27MNKD Mannkind Corp6.6M+11.9%$28M0.6%
28DSGN Design Therapeutics Inc1.8M—$26M0.6%
29ACRS Aclaris Therapeutics Inc4.9M+0.0%$26M0.6%
30STTK Shattuck Labs Inc3.8M—$26M0.6%
31KLRA Kailera Therapeutics Inc1.1M—$24M0.5%
32GLUE Monte Rosa Therapeutics Inc1.0M+0.0%$24M0.5%
33LXEO Lexeo Therapeutics Inc4.8M+9.0%$22M0.5%
34RLAY Relay Therapeutics Inc1.0M—$19M0.4%
35EOLS Evolus Inc2.6M+0.0%$18M0.4%
36IMCR Immunocore Hldgs Plc484,782+0.0%$15M0.3%
37VALN Valneva Se2.3M+0.0%$12M0.3%
38NAMS Newamsterdam Pharma Company500,333+0.0%$11M0.2%
39AUTL Autolus Therapeutics Ltd4.4M+0.0%$7M0.2%
40XLO Xilio Therapeutics Inc422,505+0.0%$4M0.1%
41IBIO Ibio Inc2.0M+0.0%$3M0.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.